CRP and pneumonia: Beyond CRP, immune cell-derived markers such as the NLR have been associated with PPC risk in lung-cancer surgical cohorts [105], while infection-oriented biomarkers such as PCT, alone or combined with cytokine dynamics, can aid early identification of postoperative pneumonia in selected settings [44,287].